Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events fast track appraisal hst evaluation overview nice 2017
… and HTA agencies (e.g., private insurers, CMS, CADTH, NICE, IQWiG, HAS) about your new product, we can help you … on our payer advisory panel, including a current member of NICE’s appraisal committee, the Chief Medical Officer of a major …
… Carers and Family Members in HTAs: a Case Study of Recent NICE Appraisals in the UK Basarir H, Brockbank J, Knight C, … that caregiver utility should be included in the economic evaluation, where relevant, among the 58 appraisals completed … In 2 appraisals where carer utility was not included, the Appraisal Committee specifically pointed out that it was …
… Early Dialog with NICE and EUnetHTA See the research: Early dialogue with NICE and EUnetHTA: a UK perspective in a politically … services offered by HTA bodies – EUnetHTA in Europe and NICE in the UK. These services are designed to guide the …
… Psychometric Evaluation Our psychometricians have extensive experience … studies to collect data to support psychometric evaluation (independent from clinical trials) Equivalence … psychometric team will help you determine the appropriate evaluation steps and analyses to maximize the value of both …
… Budget impact analyses Validation with payers Our track record of successfully supporting submissions in major … Republic of Ireland: NCPE Sweden: TLV United Kingdom: NICE , SMC, AWMSG In addition to global HTA submissions, we …
… and standard gamble - Capture utility data real-time, as events occur, via mobile technology solutions (e.g., … submissions (meeting the requirements of agencies such as NICE, SMC, CDR, and PBAC), value messaging , and publications …
Decision-Analytic Models Decision-analytic models provide a framework for compiling clinical and economic evidence in a systematic fashion, determining your product’s value, and communicating that value to decision makers. The reliability of any model …
… cost-effectiveness ratios, or ICERs, accepted by TLV from 2017 through 2022. We examined data on TLV ICERs, disease … of reimbursement decisions on orphan drugs in Sweden from 2017 through 2022 . Poster presented at the ISPOR Europe …
… Gene Therapy Keep your gene therapy development on track The paradigm of regenerative medicine development is … approval. If your advanced-therapy product has received fast-track designation, like the US FDA’s Regenerative Medicine …
… EQ-5D, or SF-6D. Methodological Guidelines: Economic Evaluation Guideline. Second Edition (Brazilian Ministry of … the UK may be used. Cost-Effectiveness Analysis Critical Appraisal Procedure (Státní Ústav pro Kontrolu Léčiv, 2017); … using the EEPRU data set as described in the literature (NICE, 2019; Hernández Alava et al., 2023). • Use of HRQOL …